November 11th 2024
AHA 2024. Study authors reported a 74% lower risk of death and an 84% lower risk of MI among participants taking either a GLP-1RA or an SGLT2i.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Surv.AI Says: Real-World Insights Into the Journey for Patients With Pulmonary Arterial Hypertension
View More
Cases and Conversations: Evidence-Based Approaches to Management of CKD in Your Patients With T2DM
View More
Raising Our Game in the Management of Hyperlipidemia: New Targets, New Tactics
View More
What Regimen to Minimize Thromboembolic Risk and Bleeding?
May 9th 2014Aging baby boomers will more frequently appear in primary care offices with cardiovascular diseases that place them at high risk for both clotting and bleeding. Many will also have atrial fibrillation. Is there a sure-fire therapeutic formula for all?
Statins May Improve Erectile Dysfunction: A New Way to Encourage Compliance?
April 28th 2014The exact mechanism responsible for this effect is still open for debate. A salutatory side effect of the news may be the impact on medication adherence among men with both elevated LDL-C and erectile dysfunction.
A Wide, Slow Cardiac Rhythm in a Lethargic Patient
April 25th 2014This 32-year-old woman's family brought her to the ED after 2 days of progressive confusion, fatigue, and weakness. Her multiple medical problems included juvenile-onset diabetes mellitus. Here, more details and a management challenge.